Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factorial randomized trial of perindopril-indapamide and intensive gliclazide-based glucose control in high-risk type 2 diabetes
2005-003281-41Phase 3Completed
- Sponsor
- Servier
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of perindopril tert-butylamine and gliclazide in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Servier. Primary endpoints: Primary composite cardiovascular endpoint and Major macrovascular and microvascular complications. Started Aug 2005; status: completed.
02
Drugs
perindopril tert-butylaminegliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-003281-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003281-41.